ODP551 Halting ErbB-2 Isoforms Retrograde Transport to the Nucleus as a New Theragnostic Approach for Triple Negative Breast Cancer

Triple negative breast cancer (TNBC) is clinically defined by the absence of estrogen and progesterone receptors and the lack of membrane overexpression or gene amplification of the receptor tyrosine kinase ErbB-2/HER2. Due to its heterogeneity, clinical biomarkers and targeted therapies for this di...

Descripción completa

Detalles Bibliográficos
Autores principales: Elizalde, Patricia Virginia, Izzo, Franco, Chervo, Maria Florencia, Merin, Sharon Salma, Dupont, Agustina, Chiauzzi, Violeta, Bruni, Sofia, Petrillo, Ezequiel, Montero, Diego, Mercogliano, Maria Florencia, Proietti, Cecilia Jazmin, Schillaci, Roxana, Madera, Santiago, Russo, Rosalia Ines Cordo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Tumor Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9629326/
http://dx.doi.org/10.1210/jendso/bvac150.1804

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9629326/
http://dx.doi.org/10.1210/jendso/bvac150.1804

Ejemplares similares